Abstract
Myocardial infarction is a leading cause of mortality worldwide. Here we report that modulation of microRNA-499 (miR-499) levels affects apoptosis and the severity of myocardial infarction and cardiac dysfunction induced by ischemia-reperfusion. We found that both the α- and β-isoforms of the calcineurin catalytic subunit are direct targets of miR-499 and that miR-499 inhibits cardiomyocyte apoptosis through its suppression of calcineurin-mediated dephosphorylation of dynamin-related protein-1 (Drp1), thereby decreasing Drp1 accumulation in mitochondria and Drp1-mediated activation of the mitochondrial fission program. We also found that p53 transcriptionally downregulates miR-499 expression. Our data reveal a role for miR-499 in regulating the mitochondrial fission machinery and we suggest that modulation of miR-499 levels may provide a therapeutic approach for treating myocardial infarction.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lee, Y. et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 425, 415–419 (2003).
Basson, M. MicroRNAs loom large in the heart. Nat. Med. 13, 541 (2007).
Callis, T.E. & Wang, D.Z. Taking microRNAs to heart. Trends Mol. Med. 14, 254–260 (2008).
Caré, A. et al. MicroRNA-133 controls cardiac hypertrophy. Nat. Med. 13, 613–618 (2007).
Mann, D.L. MicroRNAs and the failing heart. N. Engl. J. Med. 356, 2644–2645 (2007).
Thum, T. et al. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 116, 258–267 (2007).
Chien, K.R. Molecular medicine: microRNAs and the tell-tale heart. Nature 447, 389–390 (2007).
Tanaka, A. & Youle, R.J. A chemical inhibitor of DRP1 uncouples mitochondrial fission and apoptosis. Mol. Cell 29, 409–410 (2008).
Suen, D.F., Norris, K.L. & Youle, R.J. Mitochondrial dynamics and apoptosis. Genes Dev. 22, 1577–1590 (2008).
Youle, R.J. & Karbowski, M. Mitochondrial fission in apoptosis. Nat. Rev. Mol. Cell Biol. 6, 657–663 (2005).
Frank, S. et al. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev. Cell 1, 515–525 (2001).
Tan, W.Q. et al. Novel cardiac apoptotic pathway: the dephosphorylation of apoptosis repressor with caspase recruitment domain by calcineurin. Circulation 118, 2268–2276 (2008).
Wang, H.G. et al. Ca2+–induced apoptosis through calcineurin dephosphorylation of BAD. Science 284, 339–343 (1999).
Kloosterman, W.P. et al. Cloning and expression of new microRNAs from zebrafish. Nucleic Acids Res. 34, 2558–2569 (2006).
Tang, X. et al. A simple array platform for microRNA analysis and its application in mouse tissues. RNA 13, 1803–1822 (2007).
Kim, H.J., Cui, X.S., Kim, E.J., Kim, W.J. & Kim, N.H. New porcine microRNA genes found by homology search. Genome 49, 1283–1286 (2006).
van Rooij, E. et al. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev. Cell 17, 662–673 (2009).
Kusano, K.F. et al. Sonic hedgehog myocardial gene therapy: tissue repair through transient reconstitution of embryonic signaling. Nat. Med. 11, 1197–1204 (2005).
Foo, R.S., Mani, K. & Kitsis, R.N. Death begets failure in the heart. J. Clin. Invest. 115, 565–571 (2005).
Shibata, R. et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK– and COX-2–dependent mechanisms. Nat. Med. 11, 1096–1103 (2005).
Harada, M. et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat. Med. 11, 305–311 (2005).
Li, Y.Z., Lu, D.Y., Tan, W.Q., Wang, J.X. & Li, P.F. p53 initiates apoptosis by transcriptionally targeting the antiapoptotic protein ARC. Mol. Cell. Biol. 28, 564–574 (2008).
Cribbs, J.T. & Strack, S. Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep. 8, 939–944 (2007).
Cereghetti, G.M. et al. Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proc. Natl. Acad. Sci. USA 105, 15803–15808 (2008).
Sandebring, A. et al. Mitochondrial alterations in PINK1 deficient cells are influenced by calcineurin–dependent dephosphorylation of dynamin-related protein 1. PLoS ONE 4, e5701 (2009).
Molkentin, J.D. Calcineurin and beyond: cardiac hypertrophic signaling. Circ. Res. 87, 731–738 (2000).
Wilkins, B.J. & Molkentin, J.D. Calcium–calcineurin signaling in the regulation of cardiac hypertrophy. Biochem. Biophys. Res. Commun. 322, 1178–1191 (2004).
Lin, Z. et al. miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy. Proc. Natl. Acad. Sci. USA 106, 12103–12108 (2009).
Zhao, Y., Samal, E. & Srivastava, D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436, 214–220 (2005).
Sano, M. et al. p53–induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 446, 444–448 (2007).
Kannan, K. et al. DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene 20, 2225–2234 (2001).
Toth, A. et al. Targeted deletion of Puma attenuates cardiomyocyte death and improves cardiac function during ischemia-reperfusion. Am. J. Physiol. Heart Circ. Physiol. 291, H52–H60 (2006).
Lim, H.W. & Molkentin, J.D. Calcineurin and human heart failure. Nat. Med. 5, 246–247 (1999).
de Frutos, S., Spangler, R., Alo, D. & Bosc, L.V. NFATc3 mediates chronic hypoxia-induced pulmonary arterial remodeling with alpha-actin up-regulation. J. Biol. Chem. 282, 15081–15089 (2007).
Cai, Q., Baxter, G.F. & Yellon, D.M. Reduction of infarct size in isolated rat heart by CsA and FK506: possible role of phosphatase inhibition. Cardiovasc. Drugs Ther. 12, 499–501 (1998).
Weinbrenner, C., Liu, G.S., Downey, J.M. & Cohen, M.V. Cyclosporine A limits myocardial infarct size even when administered after onset of ischemia. Cardiovasc. Res. 38, 678–684 (1998).
van Rooij, E., Marshall, W.S. & Olson, E.N. Toward microRNA-based therapeutics for heart disease: the sense in antisense. Circ. Res. 103, 919–928 (2008).
Zhao, Y. et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1–2. Cell 129, 303–317 (2007).
Yang, B. et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat. Med. 13, 486–491 (2007).
Corsten, M.F. et al. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res. 67, 8994–9000 (2007).
Chan, J.A., Krichevsky, A.M. & Kosik, K.S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 65, 6029–6033 (2005).
Lee, P. et al. Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo. Am. J. Physiol. Heart Circ. Physiol. 284, H456–H463 (2003).
Nakamura, T. et al. Fas-mediated apoptosis in adriamycin–induced cardiomyopathy in rats: In vivo study. Circulation 102, 572–578 (2000).
Chao, W., Shen, Y., Li, L. & Rosenzweig, A. Importance of FADD signaling in serum deprivation– and hypoxia–induced cardiomyocyte apoptosis. J. Biol. Chem. 277, 31639–31645 (2002).
Fujio, Y., Nguyen, T., Wencker, D., Kitsis, R.N. & Walsh, K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 101, 660–667 (2000).
Wang, L., Ma, W., Markovich, R., Chen, J.W. & Wang, P.H. Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I. Circ. Res. 83, 516–522 (1998).
Pimentel, D.R. et al. Reactive oxygen species mediate amplitude–dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes. Circ. Res. 89, 453–460 (2001).
Cheng, W. et al. Stretch–induced programmed myocyte cell death. J. Clin. Invest. 96, 2247–2259 (1995).
Shizukuda, Y. et al. beta-adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. Am. J. Physiol. 275, H961–H968 (1998).
Fan, G.C. et al. Small heat–shock protein Hsp20 phosphorylation inhibits beta-agonist-induced cardiac apoptosis. Circ. Res. 94, 1474–1482 (2004).
Kajstura, J. et al. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J. Mol. Cell. Cardiol. 29, 859–870 (1997).
Fisher, P.W., Salloum, F., Das, A., Hyder, H. & Kukreja, R.C. Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity. Circulation 111, 1601–1610 (2005).
van Rooij, E. et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl. Acad. Sci. USA 105, 13027–13032 (2008).
Rodriguez, A., Griffiths-Jones, S., Ashurst, J.L. & Bradley, A. Identification of mammalian microRNA host genes and transcription units. Genome Res. 14, 1902–1910 (2004).
Saini, H.K., Griffiths-Jones, S. & Enright, A.J. Genomic analysis of human microRNA transcripts. Proc. Natl. Acad. Sci. USA 104, 17719–17724 (2007).
Ozsolak, F. et al. Chromatin structure analyses identify miRNA promoters. Genes Dev. 22, 3172–3183 (2008).
Tan, W.Q., Wang, K., Lv, D.Y. & Li, P.F. Foxo3a inhibits cardiomyocyte hypertrophy through transactivating catalase. J. Biol. Chem. 283, 29730–29739 (2008).
Wang, J.X., Li, Q. & Li, P.F. Apoptosis repressor with caspase recruitment domain contributes to the chemotherapy resistance by abolishing mitochondrial fission mediated by dynamin-related protein-1. Cancer Res. 69, 492–500 (2009).
Elrod, J.W. et al. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc. Natl. Acad. Sci. USA 104, 15560–15565 (2007).
Acknowledgements
This work was supported by the National Natural Science Foundation of China (30730045, 31010103911) and the National Basic Research Program of China (973 Program, 2007CB512000, 2011CB965300). pαMHC-clone26 was kindly provided by Z. Yang (Nanjing University). CnAα and CnAβ cDNAs were kindly provided by T. Kuno (Kobe University). The antibody to phospho-Drp1 (Ser656) was kindly provided by S. Strack (University of Iowa).
Author information
Authors and Affiliations
Contributions
P.-F.L. and J.-X.W. designed research. J.-X.W. performed cellular experiments. J.-Q.J. conducted animal experiments. Y.-R.L. created 3′ UTR constructs. Q.L. and B.L. constructed adenoviruses and generated miR-499 transgenic mice. J.-P.L. measured calcium. K.W. analyzed hypertrophy. P.-F.L. and J.-X.W. wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–16 and Supplementary Methods (PDF 1681 kb)
Rights and permissions
About this article
Cite this article
Wang, JX., Jiao, JQ., Li, Q. et al. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat Med 17, 71–78 (2011). https://doi.org/10.1038/nm.2282
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.2282
This article is cited by
-
MiR-181a protects the heart against myocardial infarction by regulating mitochondrial fission via targeting programmed cell death protein 4
Scientific Reports (2024)
-
Mitochondrial quality control in cardiac ischemia/reperfusion injury: new insights into mechanisms and implications
Cell Biology and Toxicology (2023)
-
The immunoproteasome subunit β2i ameliorates myocardial ischemia/reperfusion injury by regulating Parkin-Mfn1/2-mediated mitochondrial fusion
Cellular and Molecular Life Sciences (2023)
-
The Role of P53 in Myocardial Ischemia-Reperfusion Injury
Cardiovascular Drugs and Therapy (2023)
-
Liraglutide Attenuates Myocardial Ischemia/Reperfusion Injury Through the Inhibition of Necroptosis by Activating GLP-1R/PI3K/Akt Pathway
Cardiovascular Toxicology (2023)